VistaGen Therapeutics Inc...

NASDAQ: VTGN · Real-Time Price · USD
3.31
0.35 (12.01%)
At close: Aug 15, 2025, 3:59 PM
3.32
0.27%
After-hours: Aug 15, 2025, 07:58 PM EDT

VistaGen Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Cash & Equivalents
67.13M 119.17M 16.64M 68.14M 103.11M
Short-Term Investments
13.35M n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a
Other Long-Term Assets
454K 726K 814.2K 569.1K 576.8K
Receivables
n/a n/a 274.7K 337.9K 40.6K
Inventory
n/a n/a -735.6K n/a 942.2K
Other Current Assets
1.59M 74K 528.7K 2.33M -95.4K
Total Current Assets
82.08M 120.67M 17.51M 71M 104.12M
Property-Plant & Equipment
1.81M 2.25M 2.77M 3.08M 3.59M
Goodwill & Intangibles
n/a n/a n/a n/a n/a
Total Long-Term Assets
2.27M 2.98M 3.58M 3.65M 4.16M
Total Assets
84.34M 123.65M 21.09M 74.64M 108.28M
Account Payables
653K 1.55M 2.47M 2.76M 838.3K
Deferred Revenue
2.59M 791K 714.3K 1.24M 1.42M
Short-Term Debt
n/a 550K 105K 433.3K 367.8K
Other Current Liabilities
3.36M 1.07M -6.9K 829.7K -367.8K
Total Current Liabilities
12.61M 5.12M 4.57M 5.77M 4.19M
Long-Term Debt
n/a n/a 2.13B n/a n/a
Other Long-Term Liabilities
391K 2.67M -2.13B 1.56M 6.27M
Total Long-Term Liabilities
1.34M 4.24M 4.44M 4.16M 12.11M
Total Liabilities
13.95M 9.37M 9.01M 9.93M 16.3M
Total Debt
1.51M 2.12M 2.72M 3.04M 3.72M
Common Stock
29K 27K 7.3K 206.7K 180.8K
Retained Earnings
-407.63M -356.21M -326.85M -267.6M -219.84M
Comprehensive Income
5K n/a n/a n/a n/a
Shareholders Equity
70.39M 114.29M 12.08M 64.72M 91.98M
Total Investments
13.35M n/a n/a n/a n/a